-+ 0.00%
-+ 0.00%
-+ 0.00%

*Enliven Therapeutics Appoints Kristine Ball to Bd of Directors Ahead of Planned Phase 3 Trial Initiation This Yr

Dow Jones·10/14/2026 20:32:16